← FDA DRUG APPROVALS

FDA ANDA · ANDA090142

CETIRIZINE HYDROCHLORIDE

Sponsor: SUN PHARM

APPLICATION
ANDA090142
TYPE
ANDA
ORIGINAL APPROVAL
2011-08-30
LATEST ACTION
2011-08-30
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Discontinued

Products

CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEFDiscontinued
CETIRIZINE HYDROCHLORIDE 10MG · TABLET, CHEWABLE · ORAL
CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGYDiscontinued
CETIRIZINE HYDROCHLORIDE 10MG · TABLET, CHEWABLE · ORAL
CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEFDiscontinued
CETIRIZINE HYDROCHLORIDE 5MG · TABLET, CHEWABLE · ORAL
CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGYDiscontinued
CETIRIZINE HYDROCHLORIDE 5MG · TABLET, CHEWABLE · ORAL

Approval history

2011-08-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →